Journal of Cataract & Refractive Surgery
Volume 35, Issue 7 , Pages 1260-1265 , July 2009

Experimental use of estriol for visualizing the vitreous body in the anterior chamber after posterior capsule rupture in animal models

  • Rong Huang, MD
    • ,
  • Yuichi Kaji, MD, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author: Yuichi Kaji, MD, PhD, Department of Ophthalmology, Tsukuba University Institute of Clinical Medicine, Tennoudai 1-1-1, Tsukuba Ibaraki 305-8575, Japan.
    • ,
  • Shinichi Fukuda, MD
    • ,
  • Tetsuro Oshika, MD, PhD

Received 2 January 2009 ,Revised 2 February 2009 ,Accepted 4 February 2009.

References 

  1. Vajpayee RB, Sharma N, Dada T, Gupta V, Kumar A, Dada VK. Management of posterior capsule tears. Surv Ophthalmol. 2001;45:473–488
  2. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20:554–555
  3. Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg. 2003;29:645–651
  4. Im L, Allingham RR, Singh I, Stinnett S, Fekrat S. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. J Glaucoma. 2008;17:128–132
  5. Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, et al. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology. 2007;114:289–296
  6. Valamanesh F, Torriglia A, Savoldelli M, Gandolphe C, Jeanny J-C, BenEzra D, et al. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol Vis. 2007;13:1746–1757Available at: http://www.molvis.org/molvis/v13/a195/v13a195-valamanesh.pdfAccessed February 19, 2009
  7. Kaji Y, Hiraoka T, Okamoto F, Asano H, Oshika T. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models. Acta Ophthalmol (Oxford). 2008;86:97–102
  8. Kaji Y, Hiraoka T, Okamoto F, Sato M, Hu B, Yamane N, et al. Visualizing the vitreous body in the anterior chamber using 11-deoxycortisol after posterior capsule rupture in an animal model. Ophthalmology. 2004;111:1334–1339
  9. Kaji Y, Hiraoka T, Okamoto F, Sato M, Oshika T. Clinical application of 11-deoxycortisol in visualizing prolapsed vitreous body after posterior capsule rupture in cataract surgery. J Cataract Refract Surg. 2005;31:1133–1138
  10. Suzuki T, Kinoshita Y, Tachibana M, Matsushima Y, Kobayashi Y, Adachi W, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res. 2001;22:28–33
  11. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000;78:146–153
  12. Bucolo C, Drago F. Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of σ1 recognition sites. Eur J Pharmacol. 2004;498:111–114
  13. Treister G, Mannor S. Intraocular pressure and outflow facility; effect of estrogen and combined estrogen-progestin treatment in normal human eyes. Arch Ophthalmol. 1970;83:311–318
  14. Siesky BA, Harris A, Patel C, Klaas CL, Harris M, McCranor LJ, et al. Comparison of visual function and ocular hemodynamics between pre- and post-menopausal women. Eur J Ophthalmol. 2008;18:320–323
  15. Guo S, Tutela AC, Wagner R, Caputo AR. A comparison of the effectiveness of four biostains in enhancing visualization of the vitreous. J Pediatr Ophthalmol Strabismus. 2006;43:281–284
  16. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol. 2003;121:729–730
  17. Quiram PA, Gonzales CR, Schwartz SD. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2006;141:580–582

 No author has a financial or proprietary interest in any material or method mentioned.

 Supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists, 18791259 (2006–2008), and for Scientific Research, 21592216 (2009-2011), Japan.

PII: S0886-3350(09)00284-3

doi: 10.1016/j.jcrs.2009.02.022

Journal of Cataract & Refractive Surgery
Volume 35, Issue 7 , Pages 1260-1265 , July 2009

Article Tools

* Image Usage & Resolution